CHESSA, Bernardo
 Distribuzione geografica
Continente #
NA - Nord America 3.558
AS - Asia 1.788
EU - Europa 1.275
SA - Sud America 1.080
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 65
OC - Oceania 6
Totale 7.845
Nazione #
US - Stati Uniti d'America 3.484
BR - Brasile 950
SG - Singapore 705
CN - Cina 511
UA - Ucraina 332
IT - Italia 269
DE - Germania 158
VN - Vietnam 138
HK - Hong Kong 125
SE - Svezia 105
FR - Francia 89
FI - Finlandia 79
BD - Bangladesh 61
GB - Regno Unito 59
IN - India 46
RU - Federazione Russa 38
AR - Argentina 35
TR - Turchia 33
IQ - Iraq 29
MX - Messico 27
EC - Ecuador 23
CA - Canada 22
BE - Belgio 21
CO - Colombia 21
ES - Italia 21
JP - Giappone 21
VE - Venezuela 21
ZA - Sudafrica 18
PL - Polonia 16
CZ - Repubblica Ceca 14
NL - Olanda 14
PK - Pakistan 14
PY - Paraguay 13
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
TN - Tunisia 10
KR - Corea 8
LT - Lituania 8
RO - Romania 8
AL - Albania 7
ID - Indonesia 7
KE - Kenya 7
PE - Perù 7
AU - Australia 6
DZ - Algeria 6
IL - Israele 6
JO - Giordania 6
KG - Kirghizistan 6
NP - Nepal 6
AZ - Azerbaigian 5
IR - Iran 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BO - Bolivia 4
BY - Bielorussia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
JM - Giamaica 4
KZ - Kazakistan 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
CL - Cile 3
CR - Costa Rica 3
GE - Georgia 3
HN - Honduras 3
IE - Irlanda 3
MK - Macedonia 3
OM - Oman 3
PR - Porto Rico 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
EG - Egitto 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
MY - Malesia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
IM - Isola di Man 1
MD - Moldavia 1
MN - Mongolia 1
Totale 7.773
Città #
Dallas 937
Chandler 503
Singapore 358
San Jose 241
Jacksonville 196
Ashburn 172
Hong Kong 123
Beijing 121
Princeton 114
Nanjing 91
Ann Arbor 78
Council Bluffs 71
Columbus 65
Dearborn 62
Los Angeles 62
New York 61
São Paulo 60
Lauterbourg 56
Wilmington 48
Ho Chi Minh City 45
Sassari 42
Santa Clara 41
Hanoi 39
Rio de Janeiro 37
Boardman 32
Nanchang 31
Shanghai 31
Belo Horizonte 29
Woodbridge 28
Shenyang 24
Brussels 21
Helsinki 21
Changsha 20
San Francisco 19
Cagliari 18
Mountain View 18
Tokyo 18
Campinas 17
Hebei 17
Tianjin 17
Brasília 16
Brooklyn 16
Chennai 16
Munich 16
Naples 16
Baghdad 15
Orem 15
Curitiba 14
Porto Alegre 14
San Mateo 13
Andover 12
Guarulhos 12
Jiaxing 12
Johannesburg 12
Bogotá 11
Denver 11
Falkenstein 11
Kunming 11
Norwalk 11
Tashkent 11
Toronto 11
Atlanta 10
Frankfurt am Main 10
Istanbul 10
Ningbo 10
Nuoro 10
Sumaré 10
Turin 10
Warsaw 10
Buffalo 9
Salvador 9
Asunción 8
Augusta 8
Brno 8
Fortaleza 8
Goiânia 8
Jinan 8
London 8
Mumbai 8
Poplar 8
Quito 8
Rome 8
Santo André 8
Seattle 8
Seoul 8
Sorocaba 8
Turku 8
Zhengzhou 8
Blumenau 7
Campo Grande 7
Caracas 7
Guayaquil 7
Marília 7
Milan 7
Stockholm 7
The Dalles 7
Amman 6
Ankara 6
Bishkek 6
Boston 6
Totale 4.574
Nome #
Development of a real-time PCR for detection of Mycoplasma agalactiae in bulk tank milk samples and epidemiology of infection in Sardinia 213
Anaplasma phagocytophilum, Sardinia, Italy 209
Caratterizazione antigenica della lipoproteina di membrana P48 di Mycoplasma bovis 191
First report of canine leprosy in Europe: molecular and clinical traits 177
Characterisation and Trasformant Properties of the New Ovine papillomavirus OVPV-3 172
Caratterizzazione genetica e antigenica di una lipoproteina di superficie di Mycoplasma capricolum subsp. capricolum 171
Epidemiology and genetic characterization of Border Disease Virus circulating in Sardinia 170
Diagnosi molecolare di Anaplasma phagocytophilum e A. platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “TICK-BORNE FEVER” ad eziologia sconosciuta 169
Development and Clinical Trial of a Novel DNA Vaccine as Immunotherapy during Canine Leishmaniasis 169
Isolamento e caratterizzazione del genoma di un nuovo papillomavirus associato a carcinoma squamocellulare nella pecora sarda 168
Caratterizazione molecolare ed antigenica di micoplasmi isolati da bovini in Sardegna 167
Mycoplasma lipoproteins are major determinants of neutrophil extracellular trap formation 161
Clinical and Laboratory Findings in Equine Piroplasmosis 160
A Paradigm for Virus–Host Coevolution: Sequential Counter-Adaptations between Endogenous and Exogenous Retroviruses 159
Equus asinus Papillomavirus (EaPV1) provides new insights into equine papillomavirus diversity 159
Clonaggio, espressione e purificazione della proteina vp7 di bluetongue virus 159
Characterisation of Mycoplasma capricolum P60 surface lipoprotein and its evaluation in a recombinant ELISA 157
The liposoluble proteome of Mycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane 154
Comparison of different vitrification protocols on viability after transfer of ovine blastocysts in vitro produced and in vivo derived 154
Ovis aries Papillomavirus 3: a prototype of a novel genus in the family Papillomaviridae associated with ovine squamous cell carcinoma. 152
Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States 151
Frazionamento dei subproteomi di micoplasmi agenti eziologici di agalassia contagiosa 150
Sintesi e valutazione delle proprietà immunomodulatorie di un lipopeptide diacilato derivato da Mycoplasma agalactiae 148
A Paradigm for Virus–Host Coevolution: Sequential Counter Adaptations between Endogenous and Exogenous Retroviruses 147
Genetic and antigenic characterization of the surface lipoprotein P48 of Mycoplasma bovis 145
Diagnosi molecolare di Anaplasma phagocytophilum e Anaplasma platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “tick borne fever” ad eziologia sconosciuta 144
Benefits of TEMPOL on ram semen motility and in vitro fertility: a preliminary study 140
Immunizzazione genetica di topi balbc con l’antigene p48 di Mycoplasma agalactiae 138
Detection and Characterization of Mycoplasma spp. and Salmonella spp. in Free-living European Tortoises (Testudo hermanni, Testudo graeca, and Testudo marginata) 136
Sexing of in vitro produced ovine embryos by duplex PCR 133
Molecular investigation and phylogeny of anaplasma spp. in mediterranean ruminants reveal the presence of neutrophil-tropic strains closely related to A. platys 133
Distribution and genetic characterization of border disease virus circulating in Sardinian ovine flocks 130
Un virus racconta la storia della pecora 127
Mycoplasma agalactiae MAG_5040 is a Mg2+-Dependent, Sugar-Nonspecific SNase Recognised by the Host Humoral Response during Natural Infection 127
Molecular Cloning and Expression of a surface Lipoprotein of Mycoplasma Capricolum as a Potential Antigen for Serological Diagnosis 126
Revealing the history of sheep domestication using retrovirus integrations 124
Development and clinical trial of a novel DNA vaccine as immunotherapy during canine Leishmaniasis 122
Effect of recombinant human FSH and LH on in vitro maturation of sheep oocytes; embryo development and viability 120
Identification of a novel Papillomavirus adapted to donkey skin: Equus asinus papillomavirus type 1 117
Molecular and antigenic characterization of a Mycoplasma bovis strain causing an outbreak of infectious keratoconjunctivitis 116
Allestimento di un vaccino a DNA controMycoplasma agalactiae 109
Studio e allestimento di un vaccino a dna contro M.agalactiae 109
Mycoplasma Lipoproteins are Major Determinants of Neutrophil Extracellular Trap Formation 107
The liposoluble proteome of M. agalactiae 107
Development of a Real-Time PCR for detection ofMycoplasma agalactiaein bulk tank milk samples and epidemiology of infection in Sardinia 106
Diagnosi molecolare di Anaplasma phagocytophilum e Anaplasma platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “tick borne fever” ad eziologia sconosciuta. VII Congresso Nazionale S.I.Di.L.V. Torino, 26-28 Ottobre 2005 104
Vitrification of metaphase II plate in sheep oocytes: preliminary study 99
Identification and characterization of novel Mycoplasma spp. belonging to the hominis group from griffon vultures 98
Vitrification of sheep blastocysts: the choice of protocol does appear to affect the pregnancy and lambing rate 96
The Liposoluble proteome ofMycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane 90
A Paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses 89
Vitrification-survivol of blastocystsin improved by culture with albumin and Hyaluronan 84
Sequential counter-adaptations between endogenous and exogenous retroviruses during evolution 84
Epidemiology and genetic characterization of Border Disease Virus circulating in Sardinia 83
Isolation, culture, and characterization of embryonic cell lines from vitrified sheep blastocysts 80
Identificazione, caratterizzazione genomica e filogenesi di un papillomavirus associato a carcinoma squamocellulare nella pecora sarda 80
Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice 78
Revealing the history of animal domestication and migrations using endogenous retroviruses 73
Mycoplasma agalactiaeMAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection 66
Mycoplasma agalactiaeMAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection 38
Totale 7.845
Categoria #
all - tutte 31.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022301 0 3 5 6 8 3 24 17 30 18 54 133
2022/2023878 65 89 19 160 76 137 0 107 138 15 45 27
2023/2024210 40 22 7 6 17 53 1 6 5 0 20 33
2024/20252.044 22 29 106 32 93 65 160 454 660 258 114 51
2025/20262.789 140 647 426 371 238 147 372 69 101 120 104 54
2026/2027199 56 143 0 0 0 0 0 0 0 0 0 0
Totale 7.845